Detalhe da pesquisa
1.
DUART: durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy.
Future Oncol
; 17(34): 4657-4663, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775804
2.
BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population.
Hum Genomics
; 12(1): 39, 2018 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30103829
3.
Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis.
Expert Rev Anticancer Ther
; 23(12): 1305-1313, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850939
4.
Recomendaciones para el testeo y manejo de mutaciones de resistencia T790M en cáncer de pulmón de células pequeñas / Recommendations for the testing and management of T790M resistance mutations in small cell lung cancer
Oncol. clín
; 22(3): 110-113, 2017.
Artigo
em Espanhol
| LILACS | ID: biblio-909557